Hematological manifestations of primary mitochondrial disorders

Acta Haematologica

Volumn 118, Issue 2, 2007, Pages 88-98

  Finsterer, Josef ^a  

^a KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

Author keywords

Bone marrow; Disease, multisystem; Encephalomyopathy; Mitochondrial cytopathy; Mitochondriopathy; Oxidative phosphorylation; Respiratory chain

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTIOXIDANT; BARBITURIC ACID DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIGUANIDE; CARBOPLATIN; CARVEDILOL; CORTICOSTEROID; DOXORUBICIN; FIBRIC ACID DERIVATIVE; IFOSFAMIDE; INTERFERON; IRON; LOCAL ANESTHETIC AGENT; MITOCHONDRIAL DNA; NEUROLEPTIC AGENT; PYRIDOXINE; SEVOFLURANE; TETRACYCLINE; THIAMINE; VALPROIC ACID; VITAMIN; ZIDOVUDINE;

ANEMIA; AUTOSOMAL RECESSIVE DISORDER; BARTH SYNDROME; CELL THERAPY; CLINICAL FEATURE; DIET SUPPLEMENTATION; DIFFERENTIAL DIAGNOSIS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG MECHANISM; ENCEPHALOMYOPATHY; EOSINOPHILIA; FRIEDREICH ATAXIA; GENE MUTATION; HUMAN; IRON THERAPY; KEARNS SAYRE SYNDROME; LEBER HEREDITARY OPTIC NEUROPATHY; LEUKOPENIA; MEGALOBLASTIC ANEMIA; NEUTROPENIA; OXIDATIVE PHOSPHORYLATION; PANCYTOPENIA; PRIORITY JOURNAL; RESPIRATORY CHAIN; REVIEW; SIDEROBLASTIC ANEMIA; THROMBOCYTOPENIA;

HEMATOLOGIC DISEASES; HEMATOPOIESIS; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DISEASES; SYNDROME;

EID: 34548686839     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000105676     Document Type: Review

References (91)

1. Zeviani M, Di Donato S: Mitochondrial disorders. Brain 2004;127:2153-2172.
2. Tarnopolsky MA, Raha S: Mitochondrial myopathies: diagnosis, exercise intolerance, and treatment options. Med Sci Sports Exerc 2005;37:2086-2093.
3. Zeviani M, Spinazzola A, Carelli V: Nuclear genes in mitochondrial disorders. Curr Opin Genet Dev 2003;13:262-270.
4. Zeviani M, Carelli V: Mitochondrial disorders. Curr Opin Neurol 2003;16:585-594.
5. Bindoff LA: Disorders caused by mitochondrial DNA instability. Eur J Neurol 2004;11(suppl 2):5.
6. Riggs JE, Schochet SS Jr, Fakadej AV, Papadimitriou A, DiMauro S, Crosby TW, Gutmann L, Moxley RT: Mitochondrial encephalomyopathy with decreased succinate-cytochrome c reductase activity. Neurology 1984;34:48-53.
7. Limongelli A, Schaefer J, Jackson S, Invernizzi F, Kirino Y, Suzuki T, Reichmann H, Zeviani M: Variable penetrance of a familial progressive necrotising encephalopathy due to a novel tRNA(Ile) homoplasmic mutation in the mitochondrial genome. J Med Genet 2004;41:342-349.
8. Leonard JV, Schapira AHV: Mitochondrial respiratory chain disorders I: mitochondrial DNA defects. Lancet 2000;355:299-304.
9. Fontenay M, Cathelin S, Amiot M, Gyan E, Solary E: Mitochondria in hematopoiesis and hematologic diseases. Oncogene 2006;25:4757-4767.
10. Fleming MD, Campagna DR, Haslett JN, Trenor CC 3rd, Andrews NC: A mutation in a mitochondrial transmembrane protein is responsible for the pleiotropic hematological and skeletal phenotype of flexed-tail (f/f) mice. Genes Dev 2001;15:652-657.
11. Inoue SI, Yokota M, Nakada K, Miyoshi H, Hayashi JI: Pathogenic mitochondrial DNA-induced respiration defects in hematopoietic cells result in anemia by suppressing erythroid differentiation. FEBS Lett 2007;581:1910-1916.
12. Bader-Meunier B, Mielot F, Breton-Gorius J, Cramer E, Guichard J, Landrieu P, Dommergues JP, Tchernia G: Hematologic involvement in mitochondrial cytopathies in childhood: a retrospective study of bone marrow smears. Pediatr Res 1999;46:158-162.
13. Bernier FP, Boneh A, Dennett X, Chow CW, Cleary MA, Thorburn DR: Diagnostic criteria for respiratory chain disorders in adults and children. Neurology 2002;59:1406-1411.
14. Gillis L, Kaye E: Diagnosis and management of mitochondrial diseases. Pediatr Clin North Am 2002;49:203-219.
15. Chinnery PF, Turnbull DM: Clinical features, investigation, and management of patients with defects of mitochondrial DNA. J Neurol Neurosurg Psychiatry 1997;63:559-563.
16. Fadic R, Johns DR: Clinical spectrum of mitochondrial diseases. Semin Neurol 1996;16:11-22.
17. McFarland R, Taylor RW, Turnbull DM: The neurology of mitochondrial DNA disease. Lancet Neurol 2002;i:343-351.
18. Knerr I, Metzler M, Niemeyer CM, Holter W, Gerecke A, Baumann I, Trollmann R, Repp R: Hematologic features and clinical course of an infant with Pearson syndrome caused by a novel deletion of mitochondrial DNA. J Pediatr Hematol Oncol 2003;25:948-951.
19. Rotig A, Cormier V, Blanche S, Bonnefont JP, Ledeist F, Romero N, Schmitz J, Rustin P, Fischer A, Saudubray JM: Pearson's marrow-pancreas syndrome. A multisystem mitochondrial disorder in infancy. J Clin Invest 1990;86:1601-1608.
20. Majander A, Suomalainen A, Vettenranta K, Sariola H, Perkkio M, Holmberg C, Pihko H: Congenital hypoplastic anemia, diabetes, and severe renal tubular dysfunction associated with a mitochondrial DNA deletion. Pediatr Res 1991;30:327-330.
21. Muraki K, Nishimura S, Goto Y, Nonaka I, Sakura N, Ueda K: The association between haematological manifestation and mtDNA deletions in Pearson syndrome. J Inherit Metab Dis 1997;20:697-703.
22. Morikawa Y, Matsuura N, Kakudo K, Higuchi R, Koike M, Kobayashi Y: Pearson's marrow/pancreas syndrome: a histological and genetic study. Virchows Arch A Pathol Anat Histopathol 1993;423:227-231.
23. Simonsz HJ, Barlocher K, Rotig A: Kearns-Sayre's syndrome developing in a boy who survived Pearson's syndrome caused by mitochondrial DNA deletion. Doc Ophthalmol 1992;82:73-79.
24. Casademont J, Barrientos A, Cardellach F, Rotig A, Grau JM, Montoya J, Beltran B, Cervantes F, Rozman C, Estivill X: Multiple deletions of mtDNA in two brothers with sideroblastic anemia and mitochondrial myopathy and in their asymptomatic mother. Hum Mol Genet 1994;3:1945-1949.
25. McShane MA, Hammans SR, Sweeney M, Holt IJ, Beattie TJ, Brett EM, Harding AE: Pearson syndrome and mitochondrial encephalomyopathy in a patient with a deletion of mtDNA. Am J Hum Genet 1991;48:39-42.
26. Mohri I, Taniike M, Fujimura H, Matsuoka T, Inui K, Nagai T, Okada S: A case of Kearns-Sayre syndrome showing a constant proportion of deleted mitochondrial DNA in blood cells during 6 years of follow-up. J Neurol Sci 1998;158:106-109.
27. Schapira AHV, Cock HR: Mitochondrial myopathies and encephalomyopathies. Eur J Clin Invest 1999;29:886-898.
28. Nelson I, Bonne G, Degoul F, Marsac C, Ponsot G, Lestienne P: Kearns-Sayre syndrome with sideroblastic anemia: molecular investigations. Neuropediatrics 1992;23:199-205.
29. Bernes SM, Bacino C, Prezant TR, Pearson MA, Wood TS, Fournier P, Fischel-Ghodsian N: Identical mitochondrial DNA deletion in mother with progressive external ophthalmoplegia and son with Pearson marrow-pancreas syndrome. J Pediatr 1993;123:598-602.
30. Kearns TP, Sayre GP: Retinitis pigmentosa, external ophthalmoplegia and complete heart block. Ophthalmology 1958;60:280-289.
31. Servidei S: Mitochondrial encephalomyopathies: gene mutation. Neuromuscul Disord 2004;14:107-116.
32. Carod-Artal FJ, Lopez Gallardo E, Solano A, Dahmani Y, Herrero MD, Montoya J: Mitochondrial DNA deletions in Kearns-Sayre syndrome. Neurologia 2006;21:357-364.
33. Leung TF, Hui J, Shoubridge E, Li CK, Chik KW, Shing MM, Wong GW, Yeung WL, Yuen PM: Aplastic anaemia in association with Kearns-Sayre syndrome. J Inherit Metab Dis 1999;22:86-87.
34. Fischel-Ghodsian N, Bohlman MC, Prezant TR, Graham JM Jr, Cederbaum SD, Edwards MJ: Deletion in blood mitochondrial DNA in Kearns-Sayre syndrome. Pediatr Res 1992;31:557-560.
35. Abramowicz MJ, Cochaux P, Cohen LH, Vamos E: Pernicious anaemia and hypoparathyroidism in a patient with Kearns-Sayre syndrome with mitochondrial DNA duplication. J Inherit Metab Dis 1996;19:109-111.
36. Barth PG, Valianpour F, Bowen VM, Lam J, Duran M, Vaz FM, Wanders RJ: X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): an update. Am J Med Genet 2004;126A:349-354.
37. Kuijpers TW, Maianski NA, Tool AT, Becker K, Plecko B, Valianpour F, Wanders RJ, Pereira R, Van Hove J, Verhoeven AJ, Roos D, Baas F, Barth PG: Neutrophils in Barth syndrome (BTHS) avidly bind annexin-V in the absence of apoptosis. Blood 2004;103:3915-3923.
38. Vreken P, Valianpour F, Nijtmans LG, Grivell LA, Plecko B, Wanders RJ, Barth PG: Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome. Biochem Biophys Res Commun 2000;279:378-382.
39. Schlame M, Ren M, Xu Y, Greenberg ML, Haller I: Molecular symmetry in mitochondrial cardiolipins. Chem Phys Lipids 2005;138:38-49.
40. DiMauro S, Schon EA: Mitochondrial respiratory-chain diseases. N Engl J Med 2003;348:2656-2668.
41. Scharfe C, Hauschild M, Klopstock T, Janssen AJ, Heidemann PH, Meitinger T, Jaksch M: A novel mutation in the thiamine responsive megaloblastic anaemia gene SLC19A2 in a patient with deficiency of respiratory chain complex I. J Med Genet 2000;37:669-673.
42. Patton JR, Bykhovskaya Y, Mengesha E, Bertolotto C, Fischel-Ghodsian N: Mitochondrial myopathy and sideroblastic anemia (MLASA): missense mutation in the pseudouridine synthase 1 (PUS1) gene is associated with the loss of tRNA pseudouridylation. J Biol Chem 2005;280:19823-19828.
43. Zeharia A, Fischel-Ghodsian N, Casas K, Bykhocskaya Y, Tamari H, Lev D, Mimouni M, Lerman-Sagie T: Mitochondrial myopathy, sideroblastic anemia, and lactic acidosis: an autosomal recessive syndrome in Persian Jews caused by a mutation in the PUS1 gene. J Child Neurol 2005;20:449-452.
44. Inbal A, Avissar N, Shaklai M, Kuritzky A, Schejter A, Ben-David E, Shanske S, Garty BZ: Myopathy, lactic acidosis, and sideroblastic anemia: a new syndrome. Am J Med Genet 1995;55:372-378.
45. Blatt J, Katerji A, Barmada M, Wenger SL, Penchansky L: Pancytopenia and vacuolation of marrow precursors associated with necrotizing encephalopathy. Br J Haematol 1994;86:207-209.
46. Nagashima T, Mori M, Katayama K, Nunomura M, Nishihara H, Hiraga H, Tanaka S, Goto Y, Nagashima K: Adult Leigh syndrome with mitochondrial DNA mutation at 8993. Acta Neuropathol (Berl) 1999;97:416-422.
47. Wang YL, Choi HK, Aul C, Gattermann N, Heinisch J: The MERRF mutation of mitochondrial DNA in the bone marrow of a patient with acquired idiopathic sideroblastic anemia. Am J Hematol 1999;60:83-84.
48. Goyal S, Riordan-Eva P, Coakes RL: Late onset of Leber's hereditary optic neuropathy precipitated by anaemia. Eye 2004;18:1017-1018.
49. Man PY, Turnbull DM, Chinnery PF: Leber hereditary optic neuropathy. J Med Genet 2002;39:162-169.
50. Akman CI, Sue CM, Shanske S, Tanji K, Bonilla E, Ojaimi J, Krishna S, Schubert R, Di-Mauro S: Mitochondrial DNA deletion in a child with megaloblastic anemia and recurrent encephalopathy. J Child Neurol 2004;19:258-261.
51. Van Hove JL, Shanske S, Ciacci F, Ballinger S, Shoffner JS, Wallace DC, Hanioka T, Folkers K, Bossen EH, Kussin PS: Mitochondrial myopathy with anemia, cardiomyopathy, and lactic acidosis: a distinct late onset mitochondrial disorder. Am J Med Genet 1994;51:114-120.
52. Samad FU, Engel E, Hartmann RC: Hypoplastic anemia, Friedreich's ataxia and chromosomal breakage: case report and review of similar disorders. South Med J 1973;66:135-140.
53. Reichenbach J, Schubert R, Horvath R, Petersen J, Futterer N, Malle E, Stumpf A, Gebhardt BR, Koehl U, Schraven B, Zielen S: Fatal neonatal-onset mitochondrial respiratory chain disease with T cell immunodeficiency. Pediatr Res 2006;60:321-326.
54. Tulinius MH, Oldfors A, Holme E, Larsson NG, Houshmand M, Fahleson P, Sigstrom L, Kristiansson B: Atypical presentation of multisystem disorders in two girls with mitochondrial DNA deletions. Eur J Pediatr 1995;154:35-42.
55. Bourgeron T, Chretien D, Poggi-Bach J, Doonan S, Rabier D, Letouze P, Munnich A, Rotig A, Landrieu P, Rustin P: Mutation of the fumarase gene in two siblings with progressive encephalopathy and fumarase deficiency. J Clin Invest 1994;93:2514-2518.
56. Fleming MD: The genetics of inherited sideroblastic anemias. Semin Hematol 2002;39:270-281.
57. Matthes T, Rustin P, Trachsel H, Darbellay R, Costaridou S, Xaidara A, Rideau A, Beris P: Different pathophysiological mechanisms of intramitochondrial iron accumulation in acquired and congenital sideroblastic anemia caused by mitochondrial DNA deletion. Eur J Haematol 2006;77:169-174.
58. Hellier KD, Hatchwell E, Duncombe AS, Kew J, Hammans SR: X-linked sideroblastic anaemia with ataxia: another mitochondrial disease? J Neurol Neurosurg Psychiatry 2001;70:65-69.
59. Furuyama K, Harigae H, Heller T, Hamel BC, Minder EI, Shimizu T, Kuribara T, Blijlevens N, Shibahara S, Sassa S: Arg452 substitution of the erythroid-specific 5-aminolaevulinate synthase, a hot spot mutation in X-linked sideroblastic anaemia, does not itself affect enzyme activity. Eur J Haematol 2006;76:33-41.
60. Allikmets R, Raskind WH, Hutchinson A, Schueck ND, Dean M, Koeller DM: Mutation of a putative mitochondrial iron transporter gene (ABC7) in X-linked sideroblastic anemia and ataxia (XLSA/A). Hum Mol Genet 1999;8:743-749.
61. Lill R, Kispal G: Mitochondrial ABC transporters. Res Microbiol 2001;152:331-340.
62. Maguire A, Hellier K, Hammans S, May A: X-linked cerebellar ataxia and sideroblastic anaemia associated with a missense mutation in the ABC7 gene predicting V411L. Br J Haematol 2001;115:910-917.
63. Maassen JA: Mitochondrial diabetes, diabetes and the thiamine-responsive megaloblastic anaemia syndrome and MODY-2. Diseases with common pathophysiology? Panminerva Med 2002;44:295-300.
64. Ricketts CJ, Minton JA, Samuel J, Ariyawansa I, Wales JK, Lo IF, Barrett TG: Thiamine-responsive megaloblastic anaemia syndrome: long-term follow-up and mutation analysis of seven families. Acta Paediatr 2006;95:99-104.
65. Ozdemir MA, Akcakus M, Kurtoglu S, Gunes T, Torun YA: TRMA syndrome (thiamine-responsive megaloblastic anemia): a case report and review of the literature. Pediatr Diabetes 2002;3:205-209.
66. Marriage B, Clandinin MT, Glerum DM: Nutritional cofactor treatment in mitochondrial disorders. J Am Diet Assoc 2003;103:1029-1038.
67. Heller T, Hochstetter V, Basler M, Borck V: Vitamin B6-sensitive hereditary sideroblastic anemia. Dtsch Med Wochenschr 2004;129:141-144.
68. Klepper J, Leiendecker B, Riemann E, Baumeister FA: The ketogenic diet in Germanspeaking countries: update 2003. Klin Pädiatr 2004;216:277-285.
69. Angelini C, Federico A, Reichmann H, Lombes A, Chinnery P, Turnbull D: Task force guidelines handbook: EFNS guidelines on diagnosis and management of fatty acid mitochondrial disorders. Eur J Neurol 2006;13:923-929.
70. DiMauro S, Hirano M, Schon EA: Approaches to the treatment of mitochondrial diseases. Muscle Nerve 2006;34:265-283.
71. Zaffanello M, Zamboni G: Therapeutic approach in a case of Pearson's syndrome. Minerva Pediatr 2005;57:143-146.
72. Vallance HD, Jeven G, Wallace DC, Brown MD: A case of sporadic infantile histiocytoid cardiomyopathy caused by the A8344G (MERRF) mitochondrial DNA mutation. Pediatr Cardiol 2004;25:538-540.
73. Riess ML, Eells JT, Kevin LG, Camara AK, Henry MM, Stowe DF: Attenuation of mitochondrial respiration by sevoflurane in isolated cardiac mitochondria is mediated in part by reactive oxygen species. Anesthesiology 2004;100:498-505.
74. Riess ML, Kevin LG, McCormick J, Jiang MT, Rhodes SS, Stowe DF: Anesthetic preconditioning: the role of free radicals in sevoflurane-induced attenuation of mitochondrial electron transport in guinea pig isolated hearts. Anesth Analg 2005;100:46-53.
75. Waldhauser KM, Torok M, Ha HR, Thomet U, Konrad D, Brecht K, Follath F, Krahenbuhl S: Hepatocellular toxicity and pharmacological effect of amiodarone and amiodarone derivatives. J Pharmacol Exp Ther 2006;319:1413-1423.
76. Finsterer J: Mitochondriopathies. Eur J Neurol 2004;11:163-186.
77. 2+-ATPase by propranolol. Biochem Pharmacol 1985;34:911-917.
78. Kubat K: Lactate acidosis: a rare or common disease? Vnitr Lek 1995;41:320-324.
79. Walker UA: Mitochondrial medicine for internists. Med Klin (Munich) 2000;95:689-696.
80. Cocco T, Cutecchia G, Montedoro G, Lorusso M: The antihypertensive drug carvedilol inhibits the activity of mitochondrial NADH-ubiquinone oxidoreductase. J Bioenerg Biomembr 2002;34:251-258.
81. McIntosh LJ, Hong KE, Sapolsky RM: Glucocorticoids may alter antioxidant enzyme capacity in the brain: baseline studies. Brain Res 1998;791:209-214.
82. Adachi K, Fujiura Y, Mayumi F, Nozuhara A, Sugiu Y, Sakanashi T, Hidaka T, Toshima H: A deletion of mitochondrial DNA in murine doxorubicin-induced cardiotoxicity. Biochem Biophys Res Commun 1993;195:945-951.
83. Brunmair B, Lest A, Staniek K, Gras F, Scharf N, Roden M, Nohl H, Waldhausl W, Furnsinn C: Fenofibrate impairs rat mitochondrial function by inhibition of respiratory complex I. J Pharmacol Exp Ther 2004;311:109-114.
84. Fromenty B, Pessayre D: Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol Ther 1995;67:101-154.
85. Lewis JA, Huq A, Najarro P: Inhibition of mitochondrial function by interferon. J Biol Chem 1996;271:13184-13190.
86. Finsterer J, Haberler C, Schmiedel J: Deterioration of Kearns-Sayre syndrome following articaine administration for local anesthesia. Clin Neuropharmacol 2005;28:148-149.
87. Sztark F, Payen JF, Piriou V, Rigoulet M, Ventura-Clapier R, Mazat JP, Leverve X, Janvier G: Cellular energy metabolism: physiologic and pathologic aspects. Ann Fr Anesth Reanim 1999;18:261-269.
88. Jackson-Lewis V, Przedborski S: Neuroleptic medications inhibit complex I of the electron transport chain. Ann Neurol 1994;35:244-245.
89. Sirvent P, Bordenave S, Vermaelen M, Roels B, Vassort G, Mercier J, Raynaud E, Lacampagne A: Simvastatin induces impairment in skeletal muscle while heart is protected. Biochem Biophys Res Commun 2005;338:1426-1434.
90. Silva MF, Ruiter JP, Illst L, Jakobs C, Duran M, de Almeida IT, Wanders RJ: Valproate inhibits the mitochondrial pyruvate-driven oxidative phosphorylation in vitro. J Inherit Metab Dis 1997;20:397-400.
91. Walker UA: Inherited and acquired disorders of mitochondrial DNA. Schweiz Rundsch Med Prax 2002;91:2129-2138.